COMPASS GROUP
30 SEPTEMBER 1999
Compass Group
Grant of Share Options
Compass Group plc today announces the grant of share options
to executive directors at 580p per share. The awards are as
follows:-
Ordinary Shares of 2.5p each
Nos. of Options
Total Maximum
Name Basic Award Maximum Award Holding following
Current award
M J Bailey 133,000 400,000 728,294
A P Lynch 52,000 155,000 475,000
A F Dupuis 50,000 150,000 270,000
F H Mackay 180,000 325,000 725,000
The maximum award will be exercisable only if earnings per
share increase by a minimum 12% per year. The basic award
will be exercisable only if earnings per share increase by a
minimum of 6% per year. Options will be exercisable from 29
September 2002 to 29 September 2009.
In considering these awards the remuneration committee has
recommended that the next awards to be made under the Compass
Group Long Term Incentive Plan, due on 1 October 1999, be
reduced by approximately 25% from current salary multiples.
Contact for enquiries:
Ron Morley: Compass Group PLC 01932 573000
Andrew Lynch: Compass Group PLC 01932 573000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.